APC anti-human CD366 (Tim-3), clone A180… and 3 more items

The University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, awarded a Purchase Order (PO) to BioLegend Inc., a vendor based in Pasadena, California, for specialized antibody research reagents. The contract, identified as 4800148823, was issued on October 7, 2025, with a completion date of October 14, 2025, and a total contract value of $457. The procurement includes four distinct antibody products: APC anti-human CD366 (Tim-3), APC anti-human CD62L, APC anti-human/mouse/rat CD278 (ICOS), and PE anti-human CD137 (4-1BB).

Each line item represents a single unit of a specific antibody reagent, with unit prices ranging from $82.60 to $165.90. The order is tax-exempt under number 05-8905401 and will be delivered to UNMC Shipping and Receiving, with unloading designated to Alyssa Bouska at BCC/SRT 4-1. The purchase is governed by the University of Nebraska's Standard Terms of Purchase, with payment terms set at Net 30 and shipping arranged as F.O.B. destination with freight prepaid. The contract suggests these antibodies are intended for research purposes, likely supporting scientific or medical investigations at the University of Nebraska Medical Center.